Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov 24;88(4):389-95.
eCollection 2015 Dec.

Tailoring the Treatment of Melanoma: Implications for Personalized Medicine

Linna Duan  1 , Eric M Mukherjee  2 , Deepak Narayan  3
Affiliations
Review

Tailoring the Treatment of Melanoma: Implications for Personalized Medicine

Linna Duan et al. Yale J Biol Med. .

Abstract

Oncology has been revolutionized by the ability to selectively inhibit the growth of cancerous cells while ostensibly avoiding the disruption of proteins and pathways necessary for normal cellular function. This paradigm has triggered an explosion of targeted therapies for cancer, creating a burgeoning billion-dollar industry of small molecules and monoclonal antibodies [1]. Largely due to these new treatments, spending on cancer pharmaceuticals has surpassed $100 billion worldwide [2]. In particular, the treatment of melanoma, a deadly and fast-spreading form of skin cancer, has been transformed by these new targeted therapies. In this mini-review, we summarize the progress made in the field of personalized treatment of melanoma, with an emphasis on targeted therapies. We then outline future directions for treatment, including novel cell-mediated therapies and new potential targets.

Keywords: immunotherapy; melanoma; personalized medicine; targeted therapy.

PubMed Disclaimer

References

    1. Aggarwal S. Targeted cancer therapies. Nat Rev Drug Discov. 2010;9(6):427–428. - PubMed
    1. Mullard A. Cancer market hits $100 billion. Nat Rev Drug Discov. 2015;14(6):373.
    1. Urteaga O, Pack PT. On the antiquity of melanoma. Cancer. 1966;19(5):607–610. - PubMed
    1. Rebecca VW, Sondak VK, Smalley KSM. A brief history of melanoma: from mummies to mutations. Melanoma Res. 2012;22(2):114–122. - PMC - PubMed
    1. Roguin A. Rene Theophile Hyacinthe Laënnec (1781-1826): the man behind the stethoscope. Clin Med Res. 2006;4(3):230–235. - PMC - PubMed

MeSH terms

Substances